J. Goldman & CO LP Verastem, Inc. Transaction History

J. Goldman & CO LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.54 - $4.07 $137,160 - $219,780	-54,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.57 - $4.85 $1.34 Million - $2.53 Million	-522,565 Reduced 90.63%	54,000 $220,000
Q1 2021 May 17, 2021	BUY	$1.9 - $2.82 $1.1 Million - $1.63 Million	576,565 New	576,565 $1.42 Million

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.09B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.